Package leaflet: Information for the user. SenEase 7.5 mg tablets. Sennosides

Similar documents
Dulcolax 5 mg, film-coated tablets

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

Package Leaflet: Information for the user Laxido Paediatric Plain 6.9 g, powder for oral solution

Package leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000

Package leaflet: Information for the user. Resolor 1 mg film-coated tablets Resolor 2 mg film-coated tablets prucalopride

Package leaflet: Information for the user. Omnilax 10 g powder for oral solution, sachet. Macrogol 4000

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

Package leaflet: Information for the user. Compound Macrogol Oral Powder Sugar Free

Package leaflet: Information for the user. Ursodeoxycholic Acid Tablets 150mg (Ursodeoxycholic acid)

Package leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)

Package Leaflet: Information for the User

Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol

If you need the information on this leaflet in an alternative format, such as large text, or Braille please ring from the UK:

Package leaflet: Information for the user. Levonorgestrel 1.5 mg Tablet. levonorgestrel

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the user

Package leaflet: Information for the patient

Package leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin

Package Leaflet: Information for the User Zofran tablets 4 mg and 8 mg ondansetron (as hydrochloride dihydrate)

Package leaflet: Information for the user. Co-Codamol 30mg/500mg Capsules (Codeine Phosphate Hemihydrate and Paracetamol)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Anastrozole 1 mg film-coated tablets

Bisacodyl Laxative (Pharmacy Health)

Package leaflet: Information for the patient. Forxiga 5 mg film-coated tablets Forxiga 10 mg film-coated tablets dapagliflozin

PACKAGE LEAFLET: INFORMATION FOR THE USER Nicorandil 10 mg Tablets Nicorandil 20 mg Tablets nicorandil

Motens 2 mg and 4 mg Tablets lacidipine

2. What you need to know before you take DDAVP/Desmopressin Tablets

Package leaflet: Information for the patient. Moventig 12.5 mg film-coated tablets Moventig 25 mg film-coated tablets. naloxegol

IBS Relief 135 mg Tablets Mebeverine Hydrochloride

Package leaflet: Information for the user. Ursodeoxycholic Acid Capsules 250mg (Ursodeoxycholic acid)

Package leaflet: Information for the user

Zofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the patient. Pikopil druppels voor oraal gebruik, oplossing, 7.5 mg/ml. Sodium picosulfate

Package leaflet: Information for the user. Burinex 5 mg Tablets bumetanide

If you have any questions about how Letrozole Tablets works or why this medicine has been prescribed for you, ask your doctor.

PATIENT INFORMATION LEAFLET. Calcichew* 500 mg Chewable Tablets calcium carbonate

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin

Imodium 1 mg/5 ml oral solution

PACKAGE LEAFLET. Page 1 of 6

Package leaflet: Information for the patient. Destolit 150 mg tablets Ursodeoxycholic acid

PACKAGE LEAFLET: INFORMATION FOR THE USER Irbea 75 mg film-coated tablets Irbesartan

Package leaflet: Information for the patient. Velphoro 500 mg chewable tablets Iron as sucroferric oxyhydroxide

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

PACKAGE LEAFLET DIASTABOL 50 MG TABLETS. Version 1.0 1

Package leaflet: Information for the patient. Torarese 2.5 mg tablets Torarese 5 mg tablets Torarese 10 mg tablets Torarese 20 mg tablets.

Dulcolax Tablets and Dulcolax Suppositories Bisacodyl

Read all of this leaflet carefully before you start taking this medicine

Package leaflet: Information for the patient. SIRTURO 100 mg tablets Bedaquiline

Patient leaflet: Information for the user. Paracetamol Galpharm 500mg tablets paracetamol

Ventolin Accuhaler 200 micrograms salbutamol sulfate

Package Leaflet: Information for the patient. FERROUS SULFATE TABLETS 200 mg Ferrous Sulfate

PACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES. Lubiprostone

Package leaflet: Information for the user

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

Package Leaflet: Information for the User Daraprim 25 mg tablets pyrimethamine

Package leaflet: Information for the patient. Risedronate sodium 35 mg film-coated tablets. Risedronate sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride

Package leaflet: Information for the patient. Ezetimibe 10 mg tablets ezetimibe

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

PACKAGE LEAFLET: INFORMATION FOR THE USER

Irbenida H 150mg/12,5mg film-coated tablets

Package leaflet: Information for the user. Raxone 150 mg film-coated tablets idebenone

PATIENT INFORMATION LEAFLET Cyclophosphamide 50 mg Tablets Cyclophosphamide monohydrate

Package leaflet: Information for the user. Tetrabenazine 25 mg tablets. tetrabenazine

1. What Betahistine dihydrochloride tablets is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate)

Package leaflet: Information for the user. Flutamid Stada 250 mg tablets Flutamide

Sibelium 5 mg Tablets flunarizine

Package Leaflet: Information for the User. Kemadrin tablets 5 mg procyclidine hydrochloride

Package leaflet: Information for the patient. Dexametason Abcur 4 mg tablets. Dexamethasone

Package leaflet: Information for the patient. Eklira Genuair 322 micrograms inhalation powder Aclidinium (aclidinium bromide)

SPASMEX FORTE 5mg tablets

Patient Information Leaflet Lodine* SR Tablets 600mg (etodolac) 1. WHAT LODINE SR TABLETS ARE AND WHAT THEY ARE USED FOR

Package leaflet: Information for the patient

Package Leaflet: Information for the patient. Movicol Ready to Take oral solution in sachet

Irbenida 150 mg film-coated tablets; 300 mg film-coated tablets

Package leaflet: Information for the patient

Package leaflet: Information for the patient. Lymelysal 300 mg hard capsules. lymecycline equivalent to 300 mg tetracycline

Package Leaflet: Information for the user Propecia 1 mg film-coated Tablets Finasteride

PACKAGE LEAFLET: INFORMATION FOR THE USER

NORVASC 5 mg and 10 mg tablets

Package leaflet: Information for the user. Bricanyl Turbohaler 0.5 mg/dose terbutaline sulfate

Package Leaflet: Information for the user Kemadrin 5 mg Tablets Procyclidine hydrochloride

Atrosan Devil s Claw film-coated tablets

Package leaflet: Information for the user

Package leaflet: Information for the user. Entecavir Alvogen 0,5 mg filmomhulde tabletten Entecavir Alvogen 1 mg filmomhulde tabletten Entecavir

2 What you need to know before you use Zofran Suppositories

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

PYRIDOSTIGMINE LIME TM 60MG TABLETS Pyridostigmine bromide

1 What Zofran Suppositories are and what they are used for

Zofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the user. Ezetimibe STADA 10 mg, tabletten. Ezetimibe

Package leaflet: Information for the user. Bricanyl Respules 2.5 mg/ml Nebuliser Solution terbutaline sulfate

PACKAGE LEAFLET: INFORMATION FOR THE USER. <PRODUCT NAME> 600 mg / 1,000 IU orodispersible tablets. Calcium/cholecalciferol (Vitamin D3)

Transcription:

Package leaflet: Information for the user SenEase 7.5 mg tablets Sennosides Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, please ask your doctor, pharmacist or nurse. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet: 1. What SenEase 7.5mg tablets are and what they are used for 2. What you need to know before you take SenEase 7.5mg tablets 3. How to take SenEase 7.5mg tablets 4. Possible side effects 5. How to store SenEase 7.5mg tablets 6. Contents of the pack and other information 1. What SenEase 7.5mg tablet are and what they are used for SenEase 7.5mg tablets are used for short term relief of occasional constipation. SenEase 7.5mg tablets do not help with weight loss. This medicine contains calcium sennosides. Sennosides are hydroxyanthracene glycosides derived from Senna Leaf. 2. What you need to know before you take SenEase 7.5mg tablets Do not take SenEase 7.5mg tablets; If you are allergic to Calcium Sennosides or any of the other ingredients of this medicine (listed in section 6)

If you have blockage or narrowing of the gastro-intestinal tract or bowel (ileus, intestinal obstruction or stenosis) If you have appendicitis, inflammatory bowel disease such as Crohn's disease or ulcerative colitis If you have paralysis or lack of muscle tone in the bowel (atony) If you have persistent or undiagnosed abdominal complaints e.g. pain, nausea or vomiting If you have faecal impaction or rectal bleeding for which you don t know the cause, or blood in stools If you have severe dehydration If you have already taken a laxative and you are still constipated If you have had a sudden change in bowel habit that has lasted for more than 2 weeks If you have kidney or heart failure If you are pregnant or breast-feeding If you are under 12 years of age unless advised by a medical professional Warnings and precautions Talk to your doctor, pharmacist or nurse before taking SenEase 7.5mg tablets; - If you suffer from kidney disorders - If you have been told you have an intolerance to some sugars because this medicine also contains lactose monohydrate (15.82mg per tablet) When administrating this product to incontinent adults then pads should be changed more frequently to prevent extended skin contact with faeces. It is recommended to use changes in diet and bulk forming medicines to control constipation before using this medicine. Taking other medicines and SenEase 7.5mg Tablets Tell your doctor or pharmacist before taking this medicine; - If you are taking medicines for a heart condition (e.g. cardiac glycosides, antiarrhythmic medicinal products e.g. quinidine) and medicinal products inducing QT-prolongation. - If you are taking diuretics, adrenocorticosteroids or liquorice root preparations. - If you have recently taken or might take any other medicines, including any obtained without a prescription.

Pregnancy and breast feeding You should not use SenEase 7.5mg tablets if you are pregnant or breast feeding. 3. How to take SenEase 7.5mg tablets Always take this medicine exactly as your doctor or pharmacist has told you or as described in this leaflet. Check with your doctor or pharmacist if you are not sure. For oral use only For adults, the elderly and children over the age of 12 years: The recommended dose is one to two tablets at night. The tablets should be taken with a glass of water. Children over 6 years: Not recommended unless advised by a medical professional. Children 6 years and under: Not recommended Do not take more tablets than the label or leaflet tells you to: New users should start with the lowest dose (one tablet)and increase it to the maximum dose (two tablets) if necessary. Once regularity has been regained, dosage should be reduced and treatment can then usually be stopped. Duration of use: Normally it is sufficient to take this medicinal product up to two to three times a week. Use for more than 1 2 weeks requires medical supervision. Consult your doctor, after taking this medicine: If symptoms worsen or persist If abdominal pain persists If there is no bowel movement after 3 days and laxatives are needed every day If you take more tablets than you should: Consult your doctor or pharmacist for advice, if you accidently take too many SenEase tablets. It may be harmful to - Take too much of SenEase 7.5mg Tablets or take SenEase 7.5 mg Tablets for too long This is because it may lead to:

- Imbalance of fluid and salts in the body. This can affect the tightness of muscles such as those in the bowel. It can also affect the salts in the blood. - Low levels of potassium in the blood (called 'hypokalaemia'). This can make you tired, dizzy, make your muscles weak and cause an uneven heart-beat. - A 'lazy bowel', where the muscle in the bowel becomes too relaxed. This means that bowel emptying happens less often. This can lead to long-term constipation. - Dehydration, making you thirsty, feel faint and giving you headaches. It can also mean you cannot pass enough urine. If you forget to take SenEase 7.5mg Tablets:. If you miss a dose, take your next dose when it s due. Do not take two doses at the same time to make up for a missed dose. Always consult your doctor or pharmacist if you need further advice. If you have any further questions on the use of this medicine, ask your doctor or pharmacist. 4. Possible side effects Like all medicines, this medicine can cause side effects although not everybody gets them. If any of the following or other side effects occur, stop taking this product and consult your doctor or pharmacist: allergic reactions such as local or more widespread, skin rash, hives (skin bumps) or itchiness around the anus. the product may produce abdominal pain, spasms and diarrhoea, in particular in patients with irritable colon. chronic use may cause pigmentation of the gastrointestinal tract which usually recedes when the product is no longer taken chronic use may lead to albuminuria and haematuria which is albumin or red blood cells in the urine yellow or red-brown discolouration of urine may occur during the treatment, but is harmless The frequency of the effects occurring is not known. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects you can help provide more information on the safety of this medicine. 5. How to store SenEase 7.5mg tablets Keep this medicine out of the sight and reach of children. This medicinal product does not require any special storage condition. Store in the original container. Do not use SenEase 7.5mg tablets after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of the month. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. 6. Contents of the pack and other information What SenEase 7.5mg tablet contains Each uncoated tablet contains Sennosides (as calcium salts) equivalent to 7.5mg hydroxyanthracene glycosides, calculated as Sennoside B. The other ingredients are: Lactose monohydrate, Maize starch, Calcium hydrogen phosphate, and Magnesium stearate. What SenEase 7.5mg tablet looks like and contents of the pack SenEase 7.5mg tablets are light green to brown color, round convex shaped uncoated tablet, plain on both sides. SenEase 7.5mg tablets are available in blister packs of 20 and 60 tablets and in containers of 100 or 1000 tablets. Pack sizes over 100 tablets should only be dispensed through pharmacies. Not all pack sizes may be marketed. Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder Special Concept Development (UK) Limited T/A Rx Farma Units 1-7, Colonial Way,

Watford, Hertfordshire, WD24 4YR Manufacturer Rx Farma Limited, Units 1-7, Colonial Way, Watford, Hertfordshire, WD24 4YR If you would like this leaflet in different format or want to report any side effects please contact marketing authorisation holder listed above or email at medinfo@sigmaplc.co.uk This leaflet was last revised in June 2018